- Home
- SYNA vs ARWR Comparison
SYNA vs ARWR Comparison
Compare SYNA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNA
- ARWR
- Stock Information
- Founded
- SYNA 1986
- ARWR 2003
- Country
- SYNA United States
- ARWR United States
- Employees
- SYNA N/A
- ARWR N/A
- Industry
- SYNA Computer peripheral equipment
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SYNA Technology
- ARWR Health Care
- Exchange
- SYNA Nasdaq
- ARWR Nasdaq
- Market Cap
- SYNA 2.7B
- ARWR 2.5B
- IPO Year
- SYNA 2002
- ARWR 1993
- Fundamental
- Price
- SYNA $68.02
- ARWR $36.64
- Analyst Decision
- SYNA Strong Buy
- ARWR Strong Buy
- Analyst Count
- SYNA 7
- ARWR 8
- Target Price
- SYNA $92.17
- ARWR $47.75
- AVG Volume (30 Days)
- SYNA 388.2K
- ARWR 2.4M
- Earning Date
- SYNA 11-06-2025
- ARWR 11-25-2025
- Dividend Yield
- SYNA N/A
- ARWR N/A
- EPS Growth
- SYNA N/A
- ARWR N/A
- EPS
- SYNA N/A
- ARWR N/A
- Revenue
- SYNA $1,074,300,000.00
- ARWR $572,976,000.00
- Revenue This Year
- SYNA $11.05
- ARWR $21,421.26
- Revenue Next Year
- SYNA $9.89
- ARWR N/A
- P/E Ratio
- SYNA N/A
- ARWR N/A
- Revenue Growth
- SYNA 11.98
- ARWR 2816.20
- 52 Week Low
- SYNA $41.80
- ARWR $9.57
- 52 Week High
- SYNA $89.81
- ARWR $39.42
- Technical
- Relative Strength Index (RSI)
- SYNA 38.69
- ARWR 73.44
- Support Level
- SYNA $66.44
- ARWR $36.29
- Resistance Level
- SYNA $70.40
- ARWR $39.38
- Average True Range (ATR)
- SYNA 1.90
- ARWR 1.39
- MACD
- SYNA -0.61
- ARWR 0.06
- Stochastic Oscillator
- SYNA 7.22
- ARWR 69.44
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.